Pyruvate Kinase M2 (PKM) is an isoform of pyruvate kinase that plays a crucial role in glycolysis, converting phosphoenolpyruvate to pyruvate. PKM2 is involved in the regulation of metabolic reprogramming in cancer cells, making it a potential target for cancer therapy. Inhibitors of PKM2 can alter metabolic pathways, reduce tumor growth, and induce cell death in cancer cells. At CymitQuimica, we provide PKM2 inhibitors to support your research in cancer metabolism, oncology, and therapeutic development.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.